CBDNewsBreaks – Neutra Corp. (NTRR) Subsidiary Nearing Market Release of Hemp-Based Sports Cream Expected to be Hit with Amateur and Pro Athletes

Early-stage research and development company Neutra Corp. (OTCQB: NTRR) today announced that its subsidiary VIVIS Corp. is rapidly approaching the market release of a new transdermal, hemp-based sports cream. According to the update, the company believes the new product will prove popular with amateur athletes and others seeking relief after tough workouts and performances. The announcement is the latest in Neutra’s series of bold initiatives that it undertook earlier this year to grab a share of a market analysts predict will hit $11 billion by 2026. “We’re now seeing the positive payoff of hiring a dedicated sports medicine advisor earlier this year,” Neutra’s CEO Sydney Jim said in the news release. “Our goal with that hire was to develop hemp-based CBD (cannabidiol) products geared to the expanding sports market. VIVIS’ upcoming transdermal sports cream will appeal to the rapidly growing number of active Americans wanting to improve performance, relieve aches and pains, prevent injuries and lead healthier lifestyles. And as with all VIVIS products, this sports cream will be third-party verified for consistency, potency and as contaminant-free.”

To view the full press release, visit http://cnw.fm/Ca4xU

About Neutra Corp.

Neutra Corp. (NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture—one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company’s website at http://www.NeutraInc.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at http://cnw.fm/NTRR

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

Leave a Reply